BAB 6. KESIMPULAN DAN SARAN
6.1. Kesimpulan
1. Pada pasien sepsis dijumpai peningkatan kadar PCT yang bermakna dibandingkan dengan kontrol normal.
2. Penelitian ini membuktikan bahwa kadar PCT hanya meningkat pada penyakit yang disebabkan oleh infeksi bakteri akut secara sistemik. 3. Terdapat perbedaan bermakna pada leukosit dan LED pada
Kelompok sepsis dengan kontrol.
4. Peningkatan kadar PCT dapat dijadikan untuk menegakkan diagnosa sepsis secara dini dan untuk menilai keparahan penyakit.
6.2 Saran
1. Perlu dilakukan penelitian cross sectional yang lebih lanjut tentang kadar PCT dengan jumlah sampel yang lebih banyak.
2. Perlu dilakukan pemeriksaan kadar PCT pada penderita sepsis agar dapat mengetahui prognosa dari penyakit.
DAFTAR PUSTAKA
1. Pohan HT, Pemeriksaan Procalcitonin untuk Diagnosis Infeksi Berat, dalam. Pohan HT, Widodo D editor, Penyakit Infeksi. Jakarta: FKUI; 2004. hal: 32-9
2. Meisner M, Brunkhorst FM, Reith H, Schmidt J, et al. Clinical
Experiences with a New Semi-Quantitative Solid Phase Immunoassay for Rapid Measurement of Procalcitonin. Clin Chem Lab Med, 2000; 38 (10): 989-95
3. Vienna. Procalcitonin- a New Marker of The Systemic Inflammatory Response to Infections. Klinik Fur Anasthesiaologie und Intensiv Therapie Jena, Germany. April 2, 2000
4. Simon L, Gauvin F, Amre DK, et al. Serum Procalcitonin and C-Reaktive Protein Levels as Marker of Bacterial Infection : A
Systematic Review and Meta-analysis. Clinical Infectious Diseases, 2004; 39: 206 - 17
5. Balci C, Sungurtekin H, Gurses E, et al. Usefulness of Procalcitonin for Diagnosis of Sepsis in The Intensive Care Unit. Critical Care, 2003, 7: 85-90
6. Hatherill M, Tibby SM, Sykes K, et al. Diagnostic Marker of Infection: Comparison of Procalcitonin with C-Reaktive Protein and Leucocyte Count. Arch Dis Child, 1999; 81: 417-421.
7. O'Connor E, Venkatesh B, lipman J, et al. Procalcitonin in Critical Illness. Critical Care and Resuscitation. 2001; 3: 236-243
8. Delevaux I, Andre M, Colombier M, et al. Can Procalcitonin
Measurement Help in Differentiating Between Bacterial Infection and Other Kinds of Inflammatory Processes ?. Ann Rheum Dis, 2003; 62: 337 – 340.
9. Raghavan M, Marik PE. Management of Sepsis During the Early “Golden Hours”. The Journal of Emergency Medicine, 2006, Vol 31, No.2. pp.185- 99
10. Meisner M. Biomarkers of Sepsis : Clinically Useful ?. Current Opinion in Critical Care, 2005, 11: 473 – 480.
11. Ugarte D, Silva E, Mercon D, et al. Procalcitonin Used a Marker of Infection In the Intensive Care Unit. Critical Care Medicine, 1999; 27: 498-504.
12. Brunkhorst FM, Wegscheider K, Forycki ZF, et al. Procalcitonin For Early Diagnosis and Differentiation of SIRS, Sepsis, Severe Sepsis, and Septic Shock. Jour. Intensive Care Med .2000 : 26; s148-s152
13. Poulton B. Advances in the Management of Sepsis: the Randomized Controlled Trials Behind the Surviving Sepsis Campaign Recommendations. (review). International Journal of Antimicrobial Agents 27.(2006). 97-101
14. Meisner M, Schaikowsky k, Schmidt J, et al. Procalcitonin (PCT) – Indications for a New Diagnostic Parameter of Severe Bacterial Infection and Sepsis in Tansplantation,
Immunosupression and Cardiac Assist Devices. In : Cardiovascular Engineering. 1996:1;67-76
15. Whicher J, Bienvenu J, Monneret G. Procalcitonin as an Acute Phase Marker. Ann Clin Biochem. 2001; 38: 483-493.
16. Flores Juan C, Quiros Alfredo B, Asensio J, et al. Serum
Procalcitonin in Children with Suspected Sepsis : A Comparison with C-Reaktive Protein And Neutrophil Count. Pediatr Crit Care Med 2003, Vol 4, no 2.
17. Rau B, Kruger CM, Schilling MK. Procalcitonin:Improved
Biochemical Severity Stratification and Post Operative Monitoring in Severe Abdominal Inflammation and Sepsis. Langenbecks Arch Surg, 2004; 389: 134-144.
18. Melzi Gian V, Merlini G, Finazzi S, et al. Procalcitonin Is not a Reliable Marker for the Assessment of Severity in Acute
Pancreatitis Without Infectious Complications. Clinical Chemistry, 2000; 46: 428-430
19. Meisner M. Pathobiochemistry and Clinical Use of Procalcitonin. Clinica Chimica Acta. 2002; 323: 17-29
20. Miller B, Berker KL. Procalcitonin: How a Hormone Became a Marker and Mediator of Sepsis. Swiss Med WKLY.2001;131 : 595-602
21. Dandona P, Nix D, Wilson MF, et al. Procalcitonin Increase after Endotoxin Injection in Normal Subjects. Journal of Clinical
Endocrinology and Metabolism. 1994; 79:1605-08
22. Nylen ES, Whang KT, Snider RHJ, et al. Mortality is Increased by Procalcitonin and Decresed by an Antiserum Reactive to PCT in Experimental Sepsis. Crit Care Med, 1998; 26: 1001-1006
23. Reith HB, Mittelkotter U, Wagner R, et al. Procalcitonin (PCT) in Patients with Abdominal Sepsis. Intensive Care Med. 2000; 26: S165-S169.
24. Gendrel D, Raymond J, Coste J, et al. Comparison of Procalcitonin with C-reaktive Protein, Interleukin 6 and Interferon-Alpha for Differentiation of Bacterial vs Viral Infections. Pediatr Infect Dis J. 1999; 18:875-81.
25. Meisner M, Tschaikowsky K, Schabel S, et al. PCT - Influence of Temperature, Storage, Anticoagulation and Arterial or Venous Asservation Of Blood Samples on Procalcitonin Concentrations. Eur J. Clin Chem. Clin Biochem, 1997;35 (8): 597-601
26. Gendrel D, Raymond J, Assicot M, et al. Measurement of Procalcitonin Levels in Children with Bacterial or Viral
Meningitis. Clinical Infectious Diseases, 1997; 24: 1240-42 27. Hammer C, Hobel G, Hamme S, et al. Diagnosis and
Monitoring of Inflammatory Events in Transplant Patients.In:Trull Ak, Demers LM, Holt DW, et al. Biomarkers of Disease An
United Kingdom. 2002 : 474-481
28. Lopez AF, Cubells CL, Garcia JJ, Pou JF. Procalcitonin In Pediatric Emergency Departments for the Early Diagnosis of Invasive
Bacterial Infections in Febrile Infants: Results of a Multicenter Study and Utility of a Rapid Qualitative Test for This Marker. Pediatric Infectious Disease Journal, 2003; 22: 895-903
29. Assicot M, Mackensen A, Petitjean S, et al. Induction of Circulating Procalcitonin Following Intravenous Administration of Endotoxin in Humans. Abstract International Conference on Endotoxins
Amsterdam IV. 17.5.1993
30. Balk RA. Severe Sepsis and Septic Shock, Definition,
Epidemiology and Clinical Manifestation. Crit Care Clin, 2000;16 (2) 179-92
31. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for Sepsis and Organ Failure and Guidelines for The Use of InnovativeTherapies in Sepsis. Critical Care Medicine, 1992. Vol 20 no 6
32. Levy Mm, Fink MP, Marshall JC, et al. 2001/SCCM/ESICM/ACCP/ ATS/SIS/International Sepsis Definitions Conference. Crit Care Med, 2003; 31:1250-1256
33. Delinger RP. Surviving Sepsis Compaign Guidelines for
Management of Severe Sepsis and septic Shock. Crit Care Med, 2004; 32: 858-873
34. Martin GS, Manino DM, Eaton S, Moss M. The Epidemiology of Sepsis inThe United States From 1979 Through 2000, N Engl J. Med, 2003; 348:1546-1554
35. Bloch KC. Infectious Diseases In : Mc Phee SJ, Ganong WF. Pathophysiology of Disease. Fifth Edition. New York. P:83-84 36. Appelmelk Bj, Lynn WA.The Cause of Sepsis: Bacterial Cell Component That Trigger the Cytokine Cascade. In: Dhainaut JF, Thijs L, Park G, Editors, Septic Shock. London. WB Saunders Co.2000. p. 21-39
37. Hack CE, Thijs L. Role of Inflammatory Mediators in Sepsis. In: Dhainaut JF Thijs L, Park G, eds. Septic Shock. London.WB Saunders Co. 2000. Page. 41-127
38. Olah A, Belagyi T, Issekutz A, et al. Value of Procalcitonin Quick Test in The Differentiation Between Sterile and Infected Forms of Acute Pancreatitis. Hepato-Gastroenterology 2005; 52: 243 – 245. 39. Han Yong Y, Doughty LA, Kofos D, et al. Procalcitonin Is
Persistently Increased Among Children with Poor Outcome from Bacterial Sepsis. Pediatr Crit Care Med 2003, vol 4, No 1. 40. Assicot M, Gendrel D, Carsin H, et al. High Serum Procalcitonin Concentrations In Patients with Sepsis and Infection. The Lancet, February 1993, Vol. 341. No. 8844, Page 515–518.
41. Siti Boedina Kresno. Unsur-unsur Yang Berperan Dalam Reaksi Imunologik. Dalam :Imunologi: Diagnosis dan Prosedur
42. Siti Boedina Kresno. Darah Lengkap. Dalam: Pengantar Hematologi Dan Imunohematologi. Balai Penerbit FK UI. Jakarta. 1988 :26-29. 43. Henry JB. High White Blood Cell Counts, In : Clinical Diagnosis and Management. 19 th ed. WB. Saunders. 2003; 81
44. Ronald AS, Richard AM. Laju Endap Darah. Dalam : Tinjauan Klinis Hasil Pemeriksaan Laboratorium, alih bahasa Brahm U, Edisi 11, EGC, Jakarta. 2004: 62-63.
45, Isbister JP, Pittiglio D. Harmening. Interpretasi dan Pemeriksaan Hasil Laboratorium Abnormal. Dalam : Hematologi Klinik,
alih bahasa Ronardy DH. Penerbit Hipokrates, Jakarta. 1993: 236-238
46. Tierney LM, Stephen JM, Papadakis MA. Anemia. Dalam: Diagnosis Dan Terapi Kedokteran. Alih bahasa: Abdul Gofir. Salemba Medika Jakarta. 2003: 63-69.
47. Hoffbrand AV, Pettit JE, Moss PAH. Perubahan Hematologi pada Penyakit Sistemik. Dalam : Kapita Selekta Hematologi, alih bahasa
Iyana Setiawan. Edisi 4. EGC. Jakarta. 2005. Hal: 272-273
48. Ganz T. Anemia of Chronic Disease. In : Lichtman MA, Beutler E, Kipps TJ. ed. William s Hematology. 7th ed. New York :
Mac Graw-Hill. 2006 : 565-66.
Lampiran 1 STATUS PASIEN No.MR : Tanggal pemeriksaan : 1. Identitas pasien : - Nama : Lk/Pr, Umur: Thn - Suku/Bangsa : Agama : - Pekerjaan : 2. Anamnesa : - Riwayat penyakit : - Riwayat obat-obatan : - Rawatan hari ke : 3. Status present : - Kesadaran : - Nadi : x/menit -Temperatur : 0C -Tekanan darah : mmHg - Pernafasan : x/menit 4. Pemeriksaan Fisik Kepala : Leher :
Thorak : Abdomen : Ekstremitas : 5. Pemeriksaan Laboratorium Darah Lengkap - Hb : g/dl - Ht : % - LED : mm/jam - Eritrosit : /mm3 - Lekosit : /mm3 - Trombosit : /mm3 - MCV : fl - MCH : pg - MCHC : g% - Diftel : - Morfologi : # Eritrosit : # Lekosit : #Trombosit :
•
PCTDAFTAR RIWAYAT HIDUP
IDENTITAS:
N a m a : Dr. Cut Murzalina
Tempat / tanggal lahir : Medan, 09 Oktober 1973
Agama : Islam
Pekerjaan :Pegawai Negeri Sipil Dosen Fakultas
Kedokteran. Universitas Syiah Kuala – NAD.
N I P : 132 233 197
Pangkat / Golongan : Penata Muda / III b
Alamat : Jl. Meurebo No.2 Sektor Selatan Darussalam-
NAD
KELUARGA:
S u a m i : Ikhwan Wahyudi ST
A n a k : 1. Wana Rizky Andriasta
2. Nadial Karmi
3. Dhaifina Fildzah
PENDIDIKAN:
1. SD Negeri 82 Banda Aceh Tamat tahun 1986
2. SMP Negeri 13 Darussalam Banda Aceh Tamat tahun 1989 3. SMA Negeri 3 Banda Aceh Tamat tahun 1992
4. Fakultas Kedokteran Universitas Syiah Kuala Banda Aceh Tamat tahun 2000
5.Mengikuti Pendidikan Dokter Spesialis Patologi Klinik Fakultas
Kedokteran Universitas Sumatera Utara / RSUP. H. Adam Malik Medan, mulai 2 Januari 2003 s/d sekarang.
RIWAYAT PEKERJAAN
1. Staf pengajar Fakultas Kedokteran Universitas Syiah Kuala Darussalam – NAD dari Agustus 1997 s/d Sekarang.
2. Dosen Honor Pada Akademi Keperawatan Mona dari Januari 2001 s/d Mei 2002
PERKUMPULAN PROFESI
1. Anggota Ikatan Dokter Indonesia ( IDI ) 2. Anggota muda PDS-Patklin Cabang Medan
JOURNAL READING
1. Clinical pallor is useful to detect Severe Anemia in populations where anemia is prevalent and severe
2. Salmonella sepsis caused by a plateled transfusion from a donor with a pet snake
3. Serum leptin levels are associated with Tamoxifen – Induced steatosis 4. In vitro susceptibility of staphylococci to chlorhexidine and antibiotic 5. Beneficial effect of high dietary fiber intake in patients with type 2 DM
TULISAN
1. Keanekaragaman Molekuler Virus Hepatitis B di Indonesia 2. Antimicrobial Susceptibility Testing
3. Acut Myelomonocytic Leukemia 4. Sirosis Hati
5. Proteus mirabilis pada OMSK sebelum dan sesudah mastoidektomi 6. Reaksi Imunologi pada Syndroma Stevens Johnson
7. Spektrophotometer dan Filterphotometer 8. Elektroda Ion Selektif
9. Pemantapan Kualitas di Bidang Kimia Klinik 10.Derajat Kemurnian
11.Statistik Laboratorium 12.Pengelolaan Laboratorium 13.Analisa Gas Darah
14.Serum Protein Elektrophoresis
KEGIATAN ILMIAH
1. Sebagai peserta pada Workshop Leukemia di Medan Maret 2004
2. Sebagai peserta pada The 8th International Congress of the Asian Society
of Clinical Pathology and Laboratory Medicine (ASCPaLM) di Medan Desember 2004
3. Sebagai peserta pada workshop Fibrinogen – Fibrin di Medan Desember 2004
4. Sebagai peserta pada Simposium PDS Patklin Recent Advances HIV in Diagnostik di Medan September 2005
5. Sebagai pembicara dan peserta pada Pertemuan Ilmiah Tahunan IV Patologi Klinik dengan judul ; Kadar Fibrinogen pada Penderita Hipertensi di RSUP H. Adam Malik/ RSUP Pirngadi Medan di Malang, Jawa Timur Nopember 2005